Scarica l'app Stockscreener
0.00
100.00%
-4.00
Precedente Chiudi:
$4.00
Aprire:
$0
Volume 24 ore:
0
Relative Volume:
0.00
Capitalizzazione di mercato:
$256.96M
Reddito:
-
Utile/perdita netta:
$-71.17M
Rapporto P/E:
0.00
EPS:
-1.39
Flusso di cassa netto:
$-70.97M
1 W Prestazione:
-100.00%
1M Prestazione:
-100.00%
6M Prestazione:
-100.00%
1 anno Prestazione:
-100.00%
Intervallo 1D:
$0.00
$0.00
Intervallo di 1 settimana:
$0.00
$0.00
Portata 52W:
$0.00
$6.24
Inozyme Pharma Inc Stock (INZY) Company Profile
Nome
Inozyme Pharma Inc
Settore
Industria
Telefono
857-330-4340
Indirizzo
321 SUMMER STREET, BOSTON
Confronta INZY con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
INZY
Inozyme Pharma Inc
|
0.00 | 256.96M | 0 | -71.17M | -70.97M | -1.39 |
|
VRTX
Vertex Pharmaceuticals Inc
|
392.85 | 101.51B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
577.71 | 59.52B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
447.52 | 56.69B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
653.20 | 39.57B | 3.06B | 1.28B | -614.78M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
318.85 | 36.56B | 3.81B | -644.79M | -669.77M | -6.24 |
Inozyme Pharma Inc Stock (INZY) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2024-12-12 | Iniziato | Raymond James | Outperform |
| 2024-09-12 | Iniziato | Stifel | Buy |
| 2024-08-13 | Ripresa | Jefferies | Buy |
| 2024-05-30 | Iniziato | Wells Fargo | Overweight |
| 2023-03-23 | Aggiornamento | Jefferies | Hold → Buy |
| 2022-05-26 | Iniziato | Jefferies | Hold |
| 2022-02-07 | Iniziato | H.C. Wainwright | Buy |
| 2021-11-29 | Iniziato | Needham | Buy |
| 2020-08-18 | Iniziato | BofA Securities | Buy |
| 2020-08-18 | Iniziato | Cowen | Outperform |
| 2020-08-18 | Iniziato | Piper Sandler | Overweight |
| 2020-08-18 | Iniziato | Wedbush | Outperform |
Mostra tutto
Inozyme Pharma Inc Borsa (INZY) Ultime notizie
RSI and MACD Indicate Shift in Inozyme Pharma Inc. Sentiment2025 Dividend Review & High Yield Equity Trading Tips - sundaytimes.kr
Historical volatility pattern of Inozyme Pharma Inc. visualizedTrend Reversal & Reliable Entry Point Alerts - Newser
Developing predictive dashboards with Inozyme Pharma Inc. dataDividend Hike & Weekly Momentum Picks - Newser
Published on: 2025-08-15 03:57:26 - Newser
Will Inozyme Pharma Inc. rebound enough to break evenJuly 2025 Final Week & Verified Technical Signals - Newser
Can trapped investors hope for a rebound in Inozyme Pharma Inc.Global Markets & High Accuracy Buy Signal Tips - Newser
Moving Average Crossover Confirms Uptrend in Inozyme Pharma Inc.July 2025 Setups & Fast Moving Market Watchlists - newsyoung.net
Strategies to average down on Inozyme Pharma Inc.Dollar Strength & Weekly Setup with ROI Potential - Newser
How to build a custom watchlist for Inozyme Pharma Inc.Market Growth Summary & Stock Portfolio Risk Management - Newser
Using Python tools to backtest Inozyme Pharma Inc. strategies [2025 Geopolitical Influence] - Newser
What makes Inozyme Pharma Inc. stock price move sharplyFree Market Surge Signal for Swing Traders - Newser
Will a bounce in Inozyme Pharma Inc. offer an exitDaily Swing Candidate Analysis with Chart Patterns - Newser
Evaluating Inozyme Pharma Inc. with trendline analysisROI Focused Setup Screener With Exit Markers - Newser
Will Inozyme Pharma Inc. price bounce be sustainableSummary of Trade Cycles in 5-Year Range - Newser
Analyzing Inozyme Pharma Inc. with multi timeframe chartsFree High Yield Stocks With Buy Confirmation - Newser
Will Inozyme Pharma Inc. stock go up soonHistorical Market Behavior and Trend Summary - Newser
BioMarin: Acquisition Of Inozyme Brings Forth Late-Stage ERT BMN 401 (NASDAQ:BMRN) - Seeking Alpha
How does Inozyme Pharma Inc. compare to its industry peersExceptional financial outcomes - Jammu Links News
Is Inozyme Pharma Inc. a growth stock or a value stockInvest confidently with professional market insights - Jammu Links News
Is Inozyme Pharma Inc. stock overvalued or undervaluedExceptional growth trajectory - Jammu Links News
What are Inozyme Pharma Inc. company’s key revenue driversSuperior risk-adjusted returns - Jammu Links News
What catalysts could drive Inozyme Pharma Inc. stock higher in 2025Achieve consistent profits with proven methods - Jammu Links News
What are the technical indicators suggesting about Inozyme Pharma Inc.Discover undervalued stocks before they soar - Jammu Links News
What is Inozyme Pharma Inc. company’s growth strategyFree Technical Analysis Support - Jammu Links News
What are analysts’ price targets for Inozyme Pharma Inc. in the next 12 monthsIdentify safe investments with exceptional yields - Jammu Links News
Should I hold or sell Inozyme Pharma Inc. stock in 2025Maximize gains with data-driven trading alerts - Jammu Links News
How strong is Inozyme Pharma Inc. company’s balance sheetMaximize your investment portfolio’s performance - Jammu Links News
INOZYME PHARMA Earnings Preview: Recent $INZY Insider Trading, Hedge Fund Activity, and More - Quiver Quantitative
Is it the right time to buy Inozyme Pharma Inc. stockBeginner Investor Planner With Low Risk - Jammu Links News
Using data filters to optimize entry into Inozyme Pharma Inc.Secure Asset Flow and Trend Pattern Analysis - Newser
Why Inozyme Pharma Inc. stock attracts strong analyst attentionMid Term Trade Summary - beatles.ru
What MACD signals say about Inozyme Pharma Inc.Early Entry Ideas with Momentum Potential - Newser
How Inozyme Pharma Inc. stock performs during market volatilityConsistent Profit Pattern Recognition Tools Shared - beatles.ru
Technical Models Suggest Inozyme Pharma Inc. May Rebound SoonHigh Conviction Intraday Stock Signals Detected - metal.it
Has Inozyme Pharma Inc. Stock Ever Crashed Historical Volatility ReviewTrade Safety Report with Pattern Insights - Newser
Short Interest Drops in Inozyme Pharma Inc. After RallyTrend Analysis for Safer Trades Gains Popularity - metal.it
Inozyme Pharma, Inc. (NASDAQ:INZY) Receives Average Recommendation of “Hold” from Analysts - Defense World
Long term hold vs stop loss in Inozyme Pharma Inc.Real-Time AI Sentiment and Price Forecast - Newser
Trend analysis for Inozyme Pharma Inc. this weekSupport and Resistance Zone Summary Chart - Newser
Published on: 2025-07-28 05:37:58 - Newser
Will Inozyme Pharma Inc. rebound enough to break even Free Smart Money Tracking Signal Generator - Newser
Does Inozyme Pharma Inc. stock perform well during market downturnsFree Predictions - Jammu Links News
Inozyme Pharma Inc Azioni (INZY) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.19%
0.96%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):